Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
 |
|
möglich sobald bei der ZB eingereicht worden ist.
Early detection at different stages of type 1 diabetes.
Diabetes Stoffwechs. Herz 33:74 (2024)
Type 1 diabetes can be identified years before clinical diagnosis based on the detection of multiple islet autoantibodies. Based on this and depending on glycaemic status, a distinction is made between the pre-symptomatic stages 1 and 2. In scientific studies, early detection was associated with significant health benefits at the time of diagnosis and beyond. Teplizumab, an anti-CD3 monoclonal antibody, is the first drug available in the US that has been shown to delay the onset of diabetes in stage 2 by more than 2.5 years. It may soon be available in Europe. This perspective is fuelling the debate about extending population-based screening, but it also requires ethical considerations and a clear public health framework for the medical and psychological care of those affected.
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Schlagwörter
Type 1 Diabetes; Screening; Autoantibodies; Teplizumab; Immunotherapy; Beta-cell Function; B-lymphocyte Depletion; Double-blind; New-onset; Islet Autoantibodies; Children; Risk; Ketoacidosis; Disease; Relatives
ISSN (print) / ISBN
1861-7603
Zeitschrift
Diabetes, Stoffwechsel und Herz
Quellenangaben
Band: 33,
Heft: 5,
Artikelnummer: 74
Verlag
Verl. Kirchheim und Co.
Verlagsort
Postfach 25 24, Mainz, 55015, Germany
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed